サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1378964

コネクテッドドラッグデリバリーデバイス市場：世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測

Connected Drug Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
コネクテッドドラッグデリバリーデバイス市場：世界の産業動向、シェア、市場規模、成長、機会、2023-2028年予測
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

コネクテッドドラッグデリバリーデバイスの世界市場規模は、2022年に6億5,290万米ドルに達しました。今後、IMARC Groupは、市場は2028年までに35億1,700万米ドルに達し、2022年から2028年の間に32.4%の成長率（CAGR）を示すと予測しています。

ドラッグデリバリー機器は、在宅環境における患者の監視やカウンセリングをサポートするために使用されるスマートなワイヤレス電子システムです。服用リマインダー、服薬アドヒアランス・トラッカー、センサー、モニタリング・ツールが搭載され、患者に合わせたケアのための即時フィードバックや教育ツールを提供します。これらは便利で、診療所での治療に関連するコストを削減します。その結果、接続型ドラッグデリバリーは、喘息、糖尿病、C型肝炎、高血圧、結核、多発性硬化症、臨床分離症候群、慢性閉塞性肺疾患（COPD）、肝臓・腎臓移植患者の遠隔モニタリングに広く使用されています。

コネクテッドドラッグデリバリーデバイスの需要を喚起している主な要因として、医療管理コストの急増と患者の治療成績向上に対するニーズの高まりが挙げられます。これに加えて、在宅医療への嗜好の変化も市場の成長を刺激しています。さらに、慢性疾患に罹患する個人の数が増加していることや、予防医療が重視されるようになっていることも、市場にプラスの影響を与えています。さらに、電子カルテ（EHR）を管理するための検査室や病院での接続機器の普及が、市場の成長を促進しています。これとは別に、複数のメーカーが、アプリやプログラムに接続し、データ転送を可能にし、自動追跡を可能にし、患者の安全性を最大化できるデバイスを提供しています。コネクテッドドラッグデリバリーデバイスは、リアルタイムの患者データへのアクセスも提供するため、規制当局、支払者、患者に対するアドヒアランス向上の成果を判断するために、バイオ医薬品企業による利用が増加しています。

本レポートで扱う主な質問

  • コネクテッドドラッグデリバリーデバイスの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界のコネクテッドドラッグデリバリーデバイス市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 技術別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • コネクテッドドラッグデリバリーデバイスの世界市場構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 コネクテッドドラッグデリバリーデバイスの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • コネクテッドセンサー
    • 市場動向
    • 主要セグメント
      • コネクテッド吸入器センサー
      • コネクテッドインジェクションセンサー
    • 市場予測
  • 統合型コネクテッドデバイス
    • 市場動向
    • 主要セグメント
      • コネクテッド吸入デバイス
      • コネクテッド注射デバイス
    • 市場予測

第7章 市場内訳：エンドユーザー別

  • 病院とヘルスケアプロバイダー
    • 市場動向
    • 市場予測
  • 在宅医療
    • 市場動向
    • 市場予測

第8章 市場内訳：技術別

  • Bluetooth
    • 市場動向
    • 市場予測
  • NFC
    • 市場動向
    • 市場予測
  • その他の技術
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Adherium Limited
    • BioCorp Production
    • Cohero Health Inc.（AptarGroup Inc.）
    • Elcam Medical ACS. Ltd
    • Findair Sp. z o. o.
    • Merck KGaA
    • Phillips Medisize（Molex LLC）
    • Propeller Health（Resmed Inc.）
    • Teva Pharmaceutical Industries Ltd.
    • West Pharmaceutical Services Inc.
図表

List of Figures

  • Figure 1: Global: Connected Drug Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Connected Drug Delivery Devices Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Connected Drug Delivery Devices Market: Breakup by End User (in %), 2022
  • Figure 6: Global: Connected Drug Delivery Devices Market: Breakup by Technology (in %), 2022
  • Figure 7: Global: Connected Drug Delivery Devices Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Connected Drug Delivery Devices (Connected Sensors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Connected Drug Delivery Devices (Connected Sensors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Connected Drug Delivery Devices (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Connected Drug Delivery Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Connected Drug Delivery Devices (Bluetooth) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Connected Drug Delivery Devices (Bluetooth) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Connected Drug Delivery Devices (NFC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Connected Drug Delivery Devices (NFC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Connected Drug Delivery Devices (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Connected Drug Delivery Devices (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: North America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: North America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: United States: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: United States: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Canada: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Canada: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Asia-Pacific: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Asia-Pacific: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: China: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: China: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Japan: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Japan: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: India: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: India: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: South Korea: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: South Korea: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Australia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Australia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Indonesia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Indonesia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Europe: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Europe: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Germany: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Germany: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: France: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: France: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: United Kingdom: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: United Kingdom: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Italy: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Italy: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Spain: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Spain: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Russia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Russia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Latin America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Latin America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Brazil: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Brazil: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Mexico: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Mexico: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Middle East and Africa: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Middle East and Africa: Connected Drug Delivery Devices Market: Breakup by Country (in %), 2022
  • Figure 70: Middle East and Africa: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Global: Connected Drug Delivery Devices Industry: SWOT Analysis
  • Figure 72: Global: Connected Drug Delivery Devices Industry: Value Chain Analysis
  • Figure 73: Global: Connected Drug Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Connected Drug Delivery Devices Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Connected Drug Delivery Devices Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 4: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Connected Drug Delivery Devices Market: Competitive Structure
  • Table 7: Global: Connected Drug Delivery Devices Market: Key Players
目次
Product Code: SR112023A3738

Abstract

The global connected drug delivery devices market size reached US$ 652.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 3,517.0 Million by 2028, exhibiting a growth rate (CAGR) of 32.4% during 2022-2028.

Connected drug delivery devices are smart wireless electronic systems used to support patient supervision and counseling in home settings. They are equipped with dose reminders, adherence trackers, sensors and monitoring tools to provide instant feedback and education tools for personalized patient care. They are convenient and save costs associated with clinic-based treatment. Consequently, connected drug delivery devices are widely used in the remote monitoring of patients with asthma, diabetes, hepatitis C, hypertension, tuberculosis, multiple sclerosis, clinically isolated syndrome, chronic obstructive pulmonary disease (COPD), and liver and renal transplant recipients.

The rapidly increasing cost of medical management and the rising need to improve patient treatment outcomes are among the main factors catalyzing the demand for connected drug delivery devices. Besides this, a shift in preferences towards home-based care is also stimulating the market growth. Moreover, the rising number of individuals suffering from chronic diseases, along with the increasing emphasis on preventive care, is influencing the market positively. Furthermore, the widespread adoption of connected devices in laboratories and hospitals for maintaining electronic health records (EHR) is driving the market growth. Apart from this, several manufacturers are offering devices that can connect to apps and programs, allow data transfer, enable automated tracking, and maximize patient safety. As they also provide access to real-time patient data, connected drug delivery devices are increasingly being utilized by biopharma companies for determining adherence improvement outcomes to regulators, payers, and patients.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global connected drug delivery devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, end user and technology.

Breakup by Product:

Connected Sensors

Connected Inhaler Sensors

Connectable Injection Sensors

Integrated Connected Devices

Connected Inhalation Devices

Connected Injection Devices

Breakup by End User:

Hospitals and Healthcare Providers

Homecare

Breakup by Technology:

Bluetooth

NFC

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc.

Key Questions Answered in This Report:

  • How has the global connected drug delivery devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global connected drug delivery devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What is the breakup of the market based on the technology?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global connected drug delivery devices market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Connected Drug Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Connected Sensors
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Connected Inhaler Sensors
      • 6.1.2.2 Connectable Injection Sensors
    • 6.1.3 Market Forecast
  • 6.2 Integrated Connected Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Connected Inhalation Devices
      • 6.2.2.2 Connected Injection Devices
    • 6.2.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Healthcare Providers
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Homecare
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Bluetooth
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 NFC
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Other Technologies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BioCorp Production
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Cohero Health Inc. (AptarGroup Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Elcam Medical ACS. Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Findair Sp. z o. o.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Phillips Medisize (Molex LLC)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Propeller Health (Resmed Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 West Pharmaceutical Services Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis